Ordering the multiple pathways of apoptosis

Trends in Cardiovascular Medicine

Volumn 7, Issue 8, 1997, Pages 294-301

  Park, David S ^a   Stefanis, Leonidas ^b   Greene, Lloyd A ^a  

^a Center for Neurobiology and Behavior   (United States)

^b The New York Presbyterian Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; FAS ANTIGEN; INTERLEUKIN 1BETA CONVERTING ENZYME; PROTEIN BCL 2; UNCLASSIFIED DRUG;

APOPTOSIS; CAENORHABDITIS ELEGANS; CELL CYCLE; CELL DEATH; CELL SURVIVAL; CYTOTOXIC T LYMPHOCYTE; DNA DAMAGE; ENZYME ACTIVATION; NONHUMAN; PRIORITY JOURNAL; REVIEW;

EID: 0030720077     PISSN: 10501738     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1050-1738(97)00090-X     Document Type: Review

References (85)

1. Anderson CW: 1993. DNA damage and the DNA-activated protein kinase. Trends Biochem Sci 18:433-137.
2. Armstrong RC, Aja T, Xiang J, et al.: 1996. Fas-induced activation of the cell-death-related protease CPP32 is inhibited by bcl-2 and by ICE family protease inhibitors. J Biol Chem 271:16,850-16,855.
3. Ashkenas J, Werb Z: 1996. Proteolysis and the biochemistry of life-or-death decisions. J Exp Med 183:1947-1951.
4. Barlow C, Hirotsune S, Paylor R, et al.: 1996. ATM-deficient mice: a paradigm of ataxia telangiectasia. Cell 86:159-171.
5. Batistatou A, Merry DE, Korsmeyer SJ, Greene LA: 1993. Bcl-2 affects survival, but not neuronal differentiation of PC12 cells. J Neurosci 13:4422-4428.
6. Boldin MP, Varfolomeev EE, Pancer Z, Mett IL, Camonis JH Wallach D: 1995. A novel protein that interacts with the death domain of Fas/ apol contains a sequence motif related to the death domain. J Biol Chem 270:7795-7798.
7. Boldin MP, Goncharov TM, Goltsev YV, Wallach D: 1996. Involvement of Mach, a novel Mort1/Fadd-interacting protease, in Fas/apo1- and TNF receptor-induced cell death. Cell 85:803-815.
8. Bose R, Verheij M, Haimovitz-Friedman A, Scotto K, Fuks Z, Kolesnick R: 1995. Ceramide synthase mediates daunorubicin-induced apoptosis: an alternative mechanism for generating death signals. Cell 82:405-414.
9. Caelles C, Heinberg A, Karin M: 1994. p53-dependent apoptosis in the absence of p53-target genes. Nature 370:220-223.
10. Casaccia-Bonnefil P, Carter BD, Dobrowsky RT, Chao MV: 1996. Death of oligodendrocytes mediated by the interaction of nerve growth factor with its receptor p75. Nature 383:716-719.
11. Cheng EH-Y, Levine B, Boise LH, Thompson CB, Hardwick JM: 1996. Bax-independent inhibition of apoptosis by bcl-xL. Nature 379: 554-557.
12. Chinnaiyan AM, O'Rourke K, Tewari M, Dixit VM: 1995. FADD, a novel death domain containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell 81: 505-512.
13. Chinnaiyan AM, Orth K, O'Rourke K, Duan H, Poiriers GG, Dixit VM: 1996. Molecular ordering of the cell death pathway. J Biol Chem 271:4573-4576.
14. Chinnaiyan AM, O'Rourke K, Lane BR, Dixit VM: 1997. Interaction of ced-4 with ced-3 and ced-9: a molecular framework for cell death. Science 275:1122-1126.
15. Darmon AJ, Nicholson DW, Bleackley RC: 1995. Activation of the apoptotic protease CPP32 by cytotoxic T-cell-derived granzyme B. Nature 377:446-448.
16. Deckworth TL, Elliot JL, Knudson CM, Johnson EM Jr, Snider WD, Korsmeyer SJ: 1996. BAX is required for neuronal death after trophic factor deprivation and during development. Neuron 17:401-411.
17. Deshmukh M, Vasilakos J, Deckworth TL, Lampe PA, Shivers BD, Johnson EM Jr: 1996. Genetic and metabolic status of NGF-deprived sympathetic neurons saved by an inhibitor of ICE family proteases. J Cell Biol 135:1341-1354.
18. Dole G, Jasty R, Cooper MJ, Thompson CB, Nunez G, Castle VP: 1995. Bcl-xL is expressed in neuroblastoma cells and modulates chemotherapy-induced apoptosis. Cancer Res 55:2576-2582.
19. D'Sa-Eipper C, Subramanian T, Chinnadurai G: 1996. bfl-1, a bcl-2 homologue, suppresses p53-induced apoptosis and exhibits potent cooperative transforming activity. Cancer Res 56:3879-3882.
20. Duan H, Orth K, Chinnaiyan AM, et al.: 1996. ICE-LAP6, a novel member of the ICE/ced-3 gene family, is activated by the cytotoxic T cell protease granzyme B. J Biol Chem 271: 16,720-16,724.
21. Ellis RE, Yuan J, Horvitz HB: 1991. Mechanisms and functions of cell death. Annu Rev Cell Biol 7:663-698.
22. Enari M, Talanian RV, Wong WW, Nagata S: 1996. Sequential activation of ICE-like and CPP32-like proteases during Fas-mediated apoptosis. Nature 380:723-726.
23. Estus S, Zaks WJ, Freeman RS, Gruda M, Bravo R, Johnson EM Jr: 1994. Altered gene expression in neurons during programmed cell death: identification of c-jun as necessary for neuronal apoptosis. J Cell Biol 127:1717-1727.
24. Farinelli SE, Greene LA: 1996. Cell cycle blockers mimosine, ciclopirox, and deferoxamine prevent the death of PC12 cells and postmitotic sympathetic neurons after removal of trophic support. J Neurosci 16:1150-1162.
25. Fernandes-Alnemri T, Armstrong RC, Krebs J, et al.: 1996. In vitro activation of CPP32 and Mch3 by Mch 4, a novel human apoptotic cysteine protease containing two FADD-like domains. Proc Natl Acad Sci USA 93:7464-7469.
26. Fernandez-Sarabia MJ, Bischoff JR: 1993. Bcl-2 associates with the ras-related protein R-ras p23. Nature 366:274-275.
27. Frankowski H, Missotten M, Fernandez PA, et al.: 1995. Function and expression of the Bcl-x gene in the developing and adult nervous system. Neuroreport 6:1917-1921.
28. Fraser A, Evan G: 1996. A licence to kill. Cell 85:781-784.
29. Frisch SM, Vuori K, Kelaita D, Sicks S: 1996. A role for jun-N-terminal kinase in anoikis: suppression by bcl-2 and crmA. J Cell Biol 135:1377-1382.
30. Gagliardini V, Fernandez PA, Lee RKK, et al.: 1994. Prevention of vertebrate neuronal death by the crmA gene. Science 263:826-828.
31. Gajewski TF, Thompson CB: 1996. Apoptosis meets signal transduction: elimination of a BAD influence. Cell 87:589-592.
32. Gamen S, Marzo I, Anel A, Pineiro A, Naval J: 1996. Cpp32 inhibition prevents Fas-induced ceramide generation and apoptosis in human cells. FEBS Lett 390:233-237.
33. Gibbons HG, Dzau VJ: 1996. Molecular therapies for vascular diseases. Science 272:689-693.
34. Ham J, Babij C, Whitfield J, et al.: 1995. A c-Jun dominant negative mutant protects sympathetic neurons against programmed cell death. Neuron 14:927-939.
35. Hengartner MO, Horvitz HR: 1994. C. elegans cell survival gene ced-9 encodes a functional homolog of the mammalian proto-oncogene bcl-2. Cell 76:665-676.
36. Heusel JW, Wesselschmidt RL, Shresta S, Russel JH, Ley TJ: 1994. Cytotoxic lymphocytes require granzyme B for the rapid induction of DNA fragmentation and apoptosis an allogeneic target cells. Cell 76:977-987.
37. Itoh N, Tsujimoto Y, Nagata S: 1993. Effect of bcl-2 on Fas antigen-mediated cell death. J Immunol 151:621-627.
38. Jaattela M, Benedict M, Tewari M, Shaymn JA, Dixit VM: 1995. Bcl-x and Bcl-2 inhibit TNF and Fas-induced apoptosis and activation of phospholipase A2 in breast carcinoma cells. Oncogene 10:2297-2305.
39. James TN: 1994 Normal and abnormal consequences of apoptosis in the human heart. Circulation 90:556-573.
40. Juo P, Kuo CJ, Reynolds SE, et al.: 1997. Fas activation of the p38 mitogen-activating protein kinase signalling pathway requires ICE/ Ced-3 family proteases. Mol Cell Biol 17:24-35.
41. Kuida K, Lippke JA, Ku G, et al.: 1995. Altered cytokine export and apoptosis in mice deficient in interleukin-1β converting enzyme. Science 267:2000-2003.
42. Lazebnik YA, Takahashi A, Moir RD, et al.: 1995. Studies of the lamin proteinase reveal multiple parallel biochemical pathways during apoptotic execution. Proc Natl Acad Sci USA 92:9042-9046.
43. Lenczowski J, Dominguez L, Eder, AM, King LB, Zacharchuk CM, Ashwell JD: 1997. Lack of a role for Jun kinase and ap-1 in Fas-induced apoptosis. Mol Cell Biol 17:170-181.
44. Levine AJ: 1997. p53, the cellular gatekeeper for growth and division. Cell 88:323-331.
45. Los M, Van de Craen M, Penning LC, et al.: 1995. Requirement of an ICE/ ced3 protease for Fas/APO-1-mediated apoptosis. Nature 375:81-83.
46. Meikrantz W, Schlegel R: 1996. Suppression of apoptosis by dominant negative mutants of cyclin-dependent protein kinases. J Biol Chem 271:10,205-10,209.
47. Murcia G de, Schreiber M, Molinete B, et al.: 1994. Structure and function of poly(ADP-ribose) polymerase. Mol Cell Biochem 138: 15-24.
48. Muzio M, Chinnaiyan AM, Kischkel FC, et al.: 1996. FLICE, a novel FADD-homologous ICE/Ced-3-like protease, is recruited to the CD95 (fas/apol) death-inducing signaling complex. Cell 85:817-827.
49. Nagata S, Golstein P: 1995. The fas death factor. Science 267:1449-1456.
50. Nicholson DW, Ali A, Thornberry NA, et al.: 1995. Identification and inhibition of the ICE/Ced-3 protease necessary for mammalian apoptosis. Nature 376:37-43.
51. Oppenheim RW: 1991. Cell death during the development of the nervous system. Annu Rev Neurosci 14:453-501.
52. Orth K, O'Rourke K, Salvesen GS, Dixit VM: 1996. Molecular ordering of apoptotic mammalian ced3/ICE-like proteases. J Biol Chem 271:20,977-20,980.
53. Park DS, Stefanis L, Yan CYI, Farinelli SE, Greene LA: 1996a. Ordering the cell death pathway: differential effects of Bcl-2, an interleukin-1-converting enzyme family protease inhibitor, and other survival agents on JNK activation in serum/nerve growth factor-deprived PC12 cells. J Biol Chem 271:21,898-21,905.
54. Park DS, Farinelli SE, Greene LA: 1996b. Inhibitors of cyclin dependent kinases promote survival of post-mitotic neuronally differentiated PC12 cells and sympathetic neurons. J Biol Chem 271:8161-8169.
55. Park DS, Levine B, Ferrari G, Greene LA: 1997. Cyclin dependent kinase inhibitors and dominanat negative cyclin dependent kinase 4 and 6 promote survival of NGF-deprived sympathetic neurons. J Neurosci (in press).
56. Perry DK, Obeid LM, Hannun YA: 1996. Ceramide and the regulation of apoptosis and the stress response. Trends Cardiovasc Med 6:158-162.
57. Reed JC: 1997. Double identity for proteins of the bcl-2 family. Nature 387:773-776.
58. Sabbatini P, Lin J, Levine AJ, White E: 1995. Essential role for p53-mediated transcription in E1A-induced apoptosis. Genes Dev 9: 2184-2192.
59. Santana P, Pena LA, Haimovitz-Friedman A, et al.: 1996. Acid sphigomyelinase-deficient human lymphoblasts and mice are resistant in radiation-induced apoptosis. Cell 86:189-199.
60. Sato T, Irie S, Kitada S, Reed JC: 1995. FAP-1: a protein tyrosine phosphatase that associates with fas. Science 268:411-415.
61. cdc2 activation required for apoptosis. Science 263:1143-1145.
62. Shi L, Chen G, MacDonald G, et al.: 1996. Activation of an interleukin 1 converting enzyme-dependent apoptosis pathway by granzyme B. Proc Natl Acad Sci USA 93: 11,002-11,007.
63. Shimizu S, Eguchi Y, Kamiike W, Matsuda H, Tsujimoto Y: 1996. Bcl-2 expression prevents activation of the ICE protease cascade. Oncogene 12:2251-2257.
64. Shiver JW, Su L, Henkart PA: 1992. Cytotoxicity with target DNA breakdown by rat basophilic leukemia cells expressing both cytolysin and granzyme A. Cell 71:315-322.
65. Smith CA, Farrah T, Goodwin RG: 1994. The TNF receptor superfamily of cellular and viral proteins: activation, costimulaton, and death. Cell 76:959-962.
66. Smyth MJ, Perry DK, Zhang J, Poirier GG, Hannun YA, Obeid LM: 1996. prICE: a downstream target for ceramide-induced apoptosis and for the inhibitory action of Bcl-2. Biochem J 316:25-28.
67. Stanger BZ, Leder P, Lee TH, Kim E, Seed B: 1995. RIP: a novel protein containing a death domain that interacts with Fas/Apol. Cell 81: 513-523.
68. Stefanis L, Park DS, Yan CYI, et al.: 1996. Induction of CPP32-like activity in PC12 cells by withdrawal of trophic support: dissociation from apoptosis. J Biol Chem 271:30,663-30,671.
69. Stefanis L, Troy CM, Qi H, Greene LA: 1997. Inhibitors of trypsin-like serine proteases inhibit processing of the caspase Nedd-2 and protect PC12 cells and sympathetic neurons from death evoked by withdrawal of trophic support. J Neurochem (in press).
70. Takayama S, Sato T, Krajewski S, et al.: 1995. Cloning and functional analysis of BAG-1: a novel Bcl-2-binding protein with anti-cell death activity. Cell 80:279-284.
71. Thompson CB: 1995. Apoptosis in the pathogenesis and treatment of disease. Science 267:1456-1462.
72. Troy CM, Stefanis L, Greene LA, Shelanski ML: 1997. Nedd2 is required for apoptosis after trophic factor withdrawal, but not superoxide dismutase (SOD1) downregulation, in sympathetic neurons and PC12 cells. J Neurosci 17:1911-1918.
73. Vaux DL, Aguila HL, Weissman IL: 1992. Bcl-2 prevents death of factor-deprived cells but fails to prevent apoptosis in targets of cell mediated killing. Int Immunol 4:821-824.
74. Vaux DL: 1997. CED-4 - the third horseman of apoptosis. Cell 90:389-390.
75. Verheij M, Bose R, Lin XH, et al.: 1996. Requirement for ceramide-initiated signalling in stress-induced apoptosis. Nature 380:75-79.
76. Wang H-G, Rapp UR, Reed JC: 1996. Bcl-2 targets the protein kinase raf-1 to mitochondria. Cell 87:629-638.
77. Wang S, Miura M, Jung Y, et al.: 1996. Identification and characterization of Ich-3, a member of the interleukin-1β converting enzyme (ICE)/ced-3 family and an upstream regulator of ICE. J Biol Chem 271:20,580-20,587.
78. Wilson DJ, Fortner KA, Lynch DH, et al.: 1996. JNK, but not MAPK, activation is associated with FAS-mediated apoptosis in human T cells. Eur J Immunol 26:989-994.
79. Wyllie AH, Kerr JFR, Currie AR: 1980. Cell death: the significance of apoptosis. Int Rev Cytol 68:251-306.
80. Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME: 1995. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270:1326-1331.
81. Xue D, Shaham S, Horvitz HR: 1996. The Caenorhabditis elegans cell-death protein CED-3 is a cysteine protease with substrate specificities similar to those of the human CPP32 protease. Genes Dev 10:1073-1083.
82. Yuan J, Shaham S, Ledoux S, Ellis HM, Horvitz HB: 1993. The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1β-converting enzyme. Cell 75:641-652.
83. Zha J, Harada H, Yang E, Jockel J, Korsmeyer SJ: 1996. Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3- not bcl-xL. Cell 87:619-628.
84. Zhang J, Alter N, Reed JC, Borner C, Obeid LM, Hannun YA: 1996. Bcl-2 interrupts the ceramide-mediated pathway of cell death. Proc Natl Acad Sci USA 93:5325-5328.
85. Zou H, Henzel WJ, Liu X, et al.: 1997. Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell 90:405-413.